Peter Laird
28 results.
March 13, 2017
Research brief: Four molecular subtypes revealed in rare bile duct cancer
The short version Scientists now have a new resource for studying a rare bile duct cancer that may serve as a blueprint for placing patients…
January 3, 2017
Comprehensive study of esophageal cancer reveals several molecular subtypes, provides new insight into increasingly prevalent disease
The Cancer Genome Atlas Research Network recommends clinical trials organizers and drug manufacturers focus on newly discovered molecular subtypes
GRAND RAPIDS, Mich. (Jan. 4,…
November 16, 2016
Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis
GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from the National Cancer…
November 4, 2015
TCGA findings provide molecular background for second most common kidney cancer
GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…